摩根大通（JPMorgan）对再鼎医药的多头持仓比例增至5.31%

Core Viewpoint - JPMorgan has increased its long position in Zai Lab Limited from 4.76% to 5.31% as of January 21, 2026 [1] Group 1 - JPMorgan's long position in Zai Lab Limited reflects a growing confidence in the company's prospects [1]